Prosecution Insights
Last updated: April 19, 2026

Glycomimetics Inc.

4 pending office actions

Portfolio Summary

4
Total Pending OAs
2
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18546609 PROCESS FOR PREPARING AN E-SELECTIN INHIBITOR INTERMEDIATE KRISHNAN, GANAPATHY 1693 Non-Final OA Aug 16, 2023
18001614 COMPOSITIONS AND METHODS FOR OVERCOMING MICROENVIRONMENT-MEDIATED RESISTANCE VIA E-SELECTIN TARGETING LEE, HOI YAN NMN 1693 Final Rejection Dec 13, 2022
17998942 COMPOUNDS AND METHODS FOR REDUCTION OF CANCER CELL BURDEN AND PROTECTION OF NORMAL HEMATOPOIESIS CHO, DAVID H 1693 Final Rejection Nov 16, 2022
17597910 USE OF E-SELECTIN ANTAGONISTS TO ENHANCE THE SURVIVAL OF RECONSTITUTED, BONE MARROW-DEPLETED HOSTS GALSTER, SAMUEL LEONARD 1693 Non-Final OA Jan 28, 2022

Managing Glycomimetics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month